Skip to main content

Table 3 Secondary outcomes

From: Dexmedetomidine improved renal function in patients with severe sepsis: an exploratory analysis of a randomized controlled trial

Data fieldDEX group
(n = 54)
Non-DEX group
(n = 50)
P value
Renal replacement therapy in ICU, n (%)27 (50)29 (58)0.41
Ventilator-free days, d, median (IQR)18 (0, 23)5 (0, 20)0.09
28-day mortality, n (%)12 (22)21 (42)0.03
Hospital mortality, n (%)15 (28)26 (52)0.01
  1. DEX dexmedetomidine, ICU intensive care unit, IQR interquartile range
  2. We showed p<0.05 in italic font.